Literature DB >> 3681625

Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide.

H Rode1, R J Stunden, A J Millar, S Cywes.   

Abstract

Foregut drug receptors permit inotropic manipulation of the dysmotility pattern associated with gastroesophageal reflux (GER). Two prokinetic agents, ie, Metoclopramide and Cisapride were assessed in 18 infants with severe GER (mean age 6.5 months) by means of 18-hour continuous intraesophageal pH monitoring. Six parameters were recorded, and the results compared before and during pharmacologic stimulation. Both agents improved the parameters measured, but Cisapride was found to be more effective in enhancing lower esophageal sphincter competence and esophageal motor function. Long-term assessment of both agents in the management of GER in infants is indicated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681625     DOI: 10.1016/s0022-3468(87)80592-4

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Varicella: to vaccinate or not to vaccinate?

Authors:  A Gershon
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

2.  Alternative method of positioning the pH probe for oesophageal pH monitoring.

Authors:  A Anggiansah; N Bright; M McCullagh; K Sumboonnanonda; W J Owen
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

3.  Diagnosis and treatment of gastroesophageal reflux disease in infants and children.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

4.  The risks and benefits of cisapride in premature neonates, infants, and children.

Authors:  A Lander; A Desai
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

5.  Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.

Authors:  A Lander; R Redkar; G Nicholls; A Lawson; S R Choudhury; J J Corkery; P Gornall; R G Buick; I W Booth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

Review 6.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 7.  Efficacy and tolerability of cisapride in children.

Authors:  Y Vandenplas; A Benatar; F Cools; A Arana; B Hegar; B Hauser
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 8.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

9.  Effect of cisapride on postprandial gastro-oesophageal reflux.

Authors:  R H Holloway; J Downton; B Mitchell; J Dent
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 10.  The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis.

Authors:  Melissa Lau Moon Lin; Paula D Robinson; Jacqueline Flank; Lillian Sung; L Lee Dupuis
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.